Evidence map›Paper›PMID 36043696›Full record

ArticleeLife2022

Characterization of sequence determinants of enhancer function using natural genetic variation.

Marty G Yang, Emi Ling, Christopher J Cowley, Michael E Greenberg, Thomas Vierbuchen

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. ASPEN: Robust detection of allelic dynamics in single cell RNA-seq.bioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Association betweenGenes · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marty G Yang *Department of Neurobiology, Harvard Medical School, Boston, United States.ORCID 0000-0001-5788-3092
Emi Ling *Department of Neurobiology, Harvard Medical School, Boston, United States.ORCID 0000-0001-5287-0284
Christopher J CowleyDepartment of Neurobiology, Harvard Medical School, Boston, United States.
Michael E GreenbergDepartment of Neurobiology, Harvard Medical School, Boston, United States.ORCID 0000-0003-1380-2160
Thomas VierbuchenDevelopmental Biology Program, Sloan Kettering Institute for Cancer Research, New York, United States.ORCID 0000-0002-5690-5680
Harvard University · USKettering University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Training in the Molecular Biology of Neurodegeneration and Alzheimer's DiseaseT32AG000222 · NIA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Bruce A YANKNER · 1992 to 2026
$18.5M
Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI SCOTT Loren POMEROY, MUSTAFA SAHIN · 2021 to 2026
$9.4M
ELECTRICAL STIMULATION OF IMMEDIATE EARLY GENESR37NS028829 · NINDS · HARVARD MEDICAL SCHOOL · PI GREENBERG, MICHAEL ELDON · 1999 to 2019
$7.4M
Mechanisms Underlying Neuronal Enhancer Specification During Postnatal CNS DevelopmentR01NS115965 · NINDS · HARVARD MEDICAL SCHOOL · PI GREENBERG, MICHAEL ELDON · 2020 to 2024
$3.2M
NCI NIH HHS P30 CA008748NIA NIH HHS T32 AG000222NICHD NIH HHS P50 HD105351NIH HHS R01 NS115965NINDS NIH HHS R01 NS115965NINDS NIH HHS R37 NS028829
6 · The paper itself

Abstract

Sequence variation in enhancers that control cell-type-specific gene transcription contributes significantly to phenotypic variation within human populations. However, it remains difficult to predict precisely the effect of any given sequence variant on enhancer function due to the complexity of DNA sequence motifs that determine transcription factor (TF) binding to enhancers in their native genomic context. Using F

Indexed as

Enhancer Elements, GeneticGenetic VariationTranscription Factor AP-1AnimalsBinding SitesHumansMiceNucleotide MotifsProtein BindingTranscription Factor AP-1chromosomesenhancersgene expressiongene regulationgeneticsgenomicsmousetranscription factors

Identifiers

PMID36043696
PMCPMC9662815
OpenAlexW4293762971

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.